RenehaVis and SportVis: hyaluronate injections for joint disorders

LSP Bio Ltd has launched two products for the treatment of joint disease: RenehaVis for painful osteoarthritis of the knee and SportVis for ankle sprains and epicondylalgia of the elbow.

RenehaVis: sodium hyaluronate in a dual-chambered prefilled syringe
RenehaVis: sodium hyaluronate in a dual-chambered prefilled syringe

RenehaVis is a sodium hyaluronate product, comprising a dual-chambered prefilled syringe that enables administration of both high and low molecular weight hyaluronate in a single intra-articular injection. Using high and low molecular weight sodium hyaluronate improves both cushioning and elasticity, enabling improvement in movement and pain relief at rest and during activity.

SportVis contains STABHA (Soft Tissue Adapted Biocompatible Hyaluronic Acid) which provides a medium for tissue regeneration that reduces pain and speeds recovery. It is administered by peri-articular injection.

View RenehaVis drug record

View SportVis drug record

Further information: LSP Bio Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Ranitidine in short supply after contamination fears prompt precautionary recall

Ranitidine in short supply after contamination fears prompt precautionary recall

GPs have reported shortages of ranitidine following...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Alzhok and ranitidine oral soln.
Use our...

Excessive steroid dosing highlighted in inflammatory bowel disease

Excessive steroid dosing highlighted in inflammatory bowel disease

Some patients with Crohn's disease or ulcerative colitis...